In vitro characterization of the thyroidal uptake of O-(2-[18F]fluoroethyl)-l-tyrosine

Nuclear Medicine and Biology

Volumn 34, Issue 3, 2007, Pages 305-314

  Prante, Olaf ^a   Bläser, Daniel ^a   Maschauer, Simone ^a   Kuwert, Torsten ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

amino acid transport; FET; FRTL 5; O (2 18F fluoroethyl) l tyrosine; Thyroid

Indexed keywords

2 AMINOBICYCLO[2.2.1]HEPTAN 2 CARBOXYLIC ACID; 2 METHYL 2 METHYLAMINOPROPIONIC ACID; CARBOXYLIC ACID DERIVATIVE; FLUORODEOXYGLUCOSE F 18; O (2 FLUOROETHYL)TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; SERINE; THYROTROPIN; TRYPTOPHAN; TYROSINE METHYL ESTER; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; GLIOBLASTOMA; HUMAN; HUMAN CELL; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; THYROID TUMOR; TUMOR CELL;

ANIMALS; CELLS, CULTURED; DIDEOXYNUCLEOSIDES; HUMANS; METABOLIC CLEARANCE RATE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; SPECIES SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS;

EID: 33947311671     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2006.12.007     Document Type: Article

References (56)

1. Grünwald F., Kalicke T., Feine U., Lietzenmayer R., Scheidhauer K., Dietlein M., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 26 (1999) 1547-1552
2. Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., and Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33 (1992) 1972-1980
3. 18F]fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging 30 (2003) 267-273
4. 18F-FDG uptake in human endothelial cells in vitro. J Nucl Med 45 (2004) 455-460
5. 18F]fluoroethyl)-l-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging 29 (2002) 1039-1046
6. Kaim A.H., Weber B., Kurrer M.O., Westera G., Schweitzer A., Gottschalk J., et al. F-18-FDG and F-18-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging 29 (2002) 648-654
7. Spaeth N., Wyss M.T., Weber B., Scheidegger S., Lutz A., Verwey J., et al. Uptake of F-18-fluorocholine, F-18-fluoroethyl-l-tyrosine, and F-18-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med 45 (2004) 1931-1938
8. 131I]iodo-α-methyl-l-tyrosine in human monocyte-macrophages. Nucl Med Biol 31 (2004) 365-372
9. Jager P.L., Vaalburg W., Pruim J., de Vries E.G.E., Langen K.J., and Piers D.A. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42 (2001) 432-445
10. 18F]fluoroethyl)-l-tyrosine for tumor imaging. J Nucl Med 40 (1999) 205-212
11. 18F]fluoroethyl)-l-tyrosine. Appl Radiat Isot 57 (2002) 853-856
12. 18F]fluoroethyl)-l-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128 (2005) 678-687
13. Floeth F.W., Pauleit D., Wittsack H.J., Langen K.J., Reifenberger G., Hamacher K., et al. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with F-18 fluoroethyl-l-tyrosine and magnetic resonance spectroscopy. J Neurosurg 102 (2005) 318-327
14. 18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging 32 (2005) 1018-1025
15. 18F]fluoroethyl)-l-tyrosine in peripheral tumors: first clinical results. J Nucl Med 46 (2005) 411-416
16. 18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 33 (2006) 287-294
17. 18F]fluoroethyl)-l-tyrosine in vitro and in vivo. J Nucl Med 40 (1999) 1367-1373
18. Palacin M., Estevez R., Bertran J., and Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev 78 (1998) 969-1054
19. Langen K.J., Jarosch M., Muhlensiepen H., Hamacher K., Broer S., Jansen P., et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol 30 (2003) 501-508
20. 18F]fluoroethyl)-l-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging 33 (2006) 932-939
21. 201Tl into primary cell cultures from human thyroid tissue is multiplied by TSH. J Nucl Med 43 (2002) 145-152
22. 18F]fluorodeoxyglucose in human thyroid cells in vitro. Eur J Nucl Med Mol Imaging 31 (2004) 507-512
23. 131I-iodide. J Nucl Med 47 (2006) 1382-1388
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
25. Ambesi-Impiombato F.S., Picone R., and Tramontano D. Influence of hormones and serum on growth and differentiation of the thyroid cell strain FRTL. In: Sato G.H., Pardee A.B., and Sirbaku D.A. (Eds). Growth of cells in hormonally defined media (1982), Cold Spring Harbor Laboratory, Cold Spring Harbor (NY) 483-492
26. Brandi M.L., Rotella C.M., Mavilia C., Franceschelli F., Tanini A., and Toccafondi R. Insulin stimulates cell growth of a new strain of differentiated rat thyroid cells. Mol Cell Endocrinol 54 (1987) 91-103
27. Kimura T., Dumont J.E., Fusco A., and Golstein J. Insulin and TSH promote growth in size of PC Cl3 rat thyroid cells, possibly via a pathway different from DNA synthesis: comparison with FRTL-5 cells. Eur J Endocrinol 140 (1999) 94-103
28. Kimura T., Van Keymeulen A., Golstein J., Fusco A., Dumont J.E., and Roger P.P. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22 (2001) 631-656
29. Hosaka Y., Tawata M., Kurihara A., Ohtaka M., Endo T., and Onaya T. The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology 131 (1992) 159-165
30. Samih N., Hovsepian S., Aouani A., Lombardo D., and Fayet G. Glut-1 translocation in FRTL-5 thyroid cells: role of phosphatidylinositol 3-kinase and N-glycosylation. Endocrinology 141 (2000) 4146-4155
31. Russo D., Damante G., Foti D., Costante G., and Filetti S. Different molecular mechanisms are involved in the multihormonal control of glucose transport in FRTL5 rat thyroid cells. J Endocrinol Invest 17 (1994) 323-327
32. Spitzweg C., Joba W., Morris J.C., and Heufelder A.E. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 9 (1999) 821-830
33. Pang X.P., Park M., and Hershman J.M. Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells. Endocrinology 131 (1992) 45-50
34. Santisteban P., Kohn L.D., and Di Lauro R. Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells. J Biol Chem 262 (1987) 4048-4052
35. Lee N.T., Nayfeh S.N., and Chae C.B. Induction of nuclear protein factors specific for hormone-responsive region during activation of thyroglobulin gene by thyrotropin in rat thyroid FRTL-5 cells. J Biol Chem 264 (1989) 7523-7530
36. Grimm D., Hofstadter F., Bauer J., Spruss T., Steinbach P., Bernhardt G., et al. Establishment and characterization of a human papillary thyroid carcinoma cell line with oxyphilic differentiation (ONCO-DG 1). Virchows Arch B Cell Pathol 62 (1992) 97-104
37. Schönberger J., Bauer J., Spruss T., Weber G., Chahoud I., Eilles C., et al. Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med 78 (2000) 102-110
38. 18F]fluoroethyl)-l-tyrosine. Eur J Nucl Med Mol Imaging 30 (2003) 519-524
39. Mansi L., Moncayo R., Cuccurullo V., Dottorini M.E., and Rambaldi P.F. Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer. Q J Nucl Med Mol Imaging 48 (2004) 82-95
40. Tietze F., Kohn L.D., Kohn A.D., Bernardini I., Andersson H.C., Adamson M.D., et al. Carrier-mediated transport of monoiodotyrosine out of thyroid cell lysosomes. J Biol Chem 264 (1989) 4762-4765
41. Andersson H.C., Kohn L.D., Bernardini I., Blom H.J., Tietze F., and Gahl W.A. Characterization of lysosomal monoiodotyrosine transport in rat thyroid cells. Evidence for transport by system h. J Biol Chem 265 (1990) 10950-10954
42. Bernar J., Tietze F., Kohn L.D., Bernardini I., Harper G.S., Grollman E.F., et al. Characteristics of a lysosomal membrane transport system for tyrosine and other neutral amino acids in rat thyroid cells. J Biol Chem 261 (1986) 17107-17112
43. Deves R., and Boyd C.A. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78 (1998) 487-545
44. Kanai Y., Segawa H., Miyamoto K., Uchino H., Takeda E., and Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273 (1998) 23629-23632
45. Pineda M., Fernandez E., Torrents D., Estevez R., Lopez C., Camps M., et al. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem 274 (1999) 19738-19744
46. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 274 (1999) 19745-19751
47. Babu E., Kanai Y., Chairoungdua A., Kim do K., Iribe Y., Tangtrongsup S., et al. Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem 278 (2003) 43838-43845
48. Bodoy S., Martin L., Zorzano A., Palacin M., Estevez R., and Bertran J. Identification of LAT4, a novel amino acid transporter with system L activity. J Biol Chem 280 (2005) 12002-12011
49. Shotwell M.A., Jayme D.W., Kilberg M.S., and Oxender D.L. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem 256 (1981) 5422-5427
50. 125I]iodo-l-tyrosine into U266 human myeloma cells: evidence for system T transport. Nucl Med Biol 28 (2001) 129-134
51. 123I]Iodo-alpha-methyl-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 29 (2002) 625-631
52. 3H]methyl]-l-methionine. J Nucl Med 41 (2000) 1250-1255
53. 0+. J Biol Chem 274 (1999) 23740-23745
54. Verri T., Dimitri C., Treglia S., Storelli F., De Micheli S., Ulianich L., et al. Multiple pathways for cationic amino acid transport in rat thyroid epithelial cell line PC Cl3. Am J Physiol Cell Physiol 288 (2005) C290-C303
55. Lahoutte T., Caveliers V., Camargo S.M., Franca R., Ramadan T., Veljkovic E., et al. SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. J Nucl Med 45 (2004) 1591-1596
56. Friesema E.C., Docter R., Moerings E.P., Verrey F., Krenning E.P., Hennemann G., et al. Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology 142 (2001) 4339-4348